Pallas Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Buy |
3,059
+579
| +23% | +$258K | 0.05% | 261 |
|
|
2025
Q1 | $1.2M | Buy |
2,480
+19
| +0.8% | +$9.21K | 0.05% | 267 |
|
|
2024
Q4 | $991K | Buy |
2,461
+75
| +3% | +$30.2K | 0.04% | 234 |
|
|
2024
Q3 | $1.13M | Sell |
2,386
-5
| -0.2% | -$2.36K | 0.05% | 206 |
|
|
2024
Q2 | $1.17M | Buy |
2,391
+1,673
| +233% | +$817K | 0.05% | 195 |
|
|
2024
Q1 | $300K | Buy |
718
+128
| +22% | +$53.5K | 0.01% | 359 |
|
|
2023
Q4 | $240K | Sell |
590
-61
| -9% | -$24.8K | 0.01% | 336 |
|
|
2023
Q3 | $233K | Buy |
651
+14
| +2% | +$5K | 0.01% | 316 |
|
|
2023
Q2 | $228K | Buy |
+637
| New | +$228K | 0.01% | 242 |
|
|
2021
Q4 | – | Sell |
-1,247
| Closed | -$236K | – | 406 |
|
|
2021
Q3 | $236K | Sell |
1,247
-8,803
| -88% | -$1.67M | 0.03% | 340 |
|
|
2021
Q2 | $2.01M | Buy |
10,050
+1,657
| +20% | +$331K | 0.28% | 70 |
|
|
2021
Q1 | $1.79M | Buy |
+8,393
| New | +$1.79M | 0.4% | 52 |
|